EMS Pharma Competitors and Similar CompaniesClear all
EMS Pharma's competitors and similar companies include Biocon, Alembic Pharmaceuticals, Cipla and Livzon Pharmaceutical Group.
 EMS Pharma EMS Pharma is a company that specializes in the research, development, and manufacturing of pharmaceuticals. |  Alembic Pharmaceuticals Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates |  Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products. |  Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. | ||
Founding Date | Founding Date 1964 | Founding Date 1978 | Founding Date 2010 | Founding Date 1935 | Founding Date 1985 |
Type | Type Private | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations BR HQ | Locations Bengaluru, IN HQ Bengaluru, IN Nanakramguda, IN Dublin, IE Kuala Lumpur, MY Puchong, MY Delémont, CH see more | Locations Vadodara, IN HQ Baska, IN Mumbai, IN Namthang, IN Vadodara, IN Vadodara, IN | Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN |
Employees | Employees 12,7441% increase | Employees 16,5612% increase | Employees 14,858 | Employees 27,764 | Employees 9,067 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ₹167.8b (FY, 2026) | Revenue (est.) ₹73.4b (FY, 2026) | Revenue (est.) ₹277.1b (FY, 2026) | Revenue (est.) ¥11.7b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods ₹56.9b (FY, 2026) | Cost of goods ₹19.8b (FY, 2026) | Cost of goods ₹95.5b (FY, 2026) | Cost of goods ¥4.1b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit ₹115.8b (FY, 2026) | Gross profit ₹54.1b (FY, 2026) | Gross profit ₹195b (FY, 2026) | Gross profit ¥7.8b (FY, 2025) |
Net income | Net income N/A | Net income ₹3.7b (FY, 2026) | Net income ₹6.7b (FY, 2026) | Net income ₹38.7b (FY, 2026) | Net income ¥2.4b (FY, 2025) |
Operating ⚠ | |||||
Products | Products N/A | Products N/A | Products 145 (FY, 2024) | Products 1.5 k (FY, 2024) | Products N/A |
For sources of this data, please see the company profile
View Company Profiles
Biocon
HQ
Bengaluru, IN
Employees
16,561↑ 2% increase
Biocon is a company that develops and manufactures biopharmaceutical products.
View companyAlembic Pharmaceuticals
HQ
Vadodara, IN
Employees
14,858
Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates
View companyCipla
HQ
Mumbai, IN
Employees
27,764
Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
View companyLivzon Pharmaceutical Group
HQ
Zhuhai, CN
Employees
9,067
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View company